BD launches COVID/flu test in U.S., Europe To view this email as a web page,
click here | | Webinar: The Benefits of Pharmacist-Led Clinical Trials Tuesday, February 23, 2021 | 1pm ET / 10am PT This webinar will focus on how a pharmacist-led clinical trial model impacts the six key areas most relevant to clinical trials in today’s COVID and Decentralized Clinical Trial environment: regulations, recruiting, diversity, clinical outcomes, data integrity, and clinical supply chain. Register Now. |
House panel advances bill to boost ACA subsidies as part of COVID-19 relief package Mallinckrodt faces regulatory delay as COVID-19 restrictions continue to upend FDA's inspection schedule BD begins U.S., European rollout of new test for the flu, COVID-19 and its new strains Here's how far Medicare claims dropped last spring due to COVID-19 Biopharma roundup—Pfizer, Moderna boost U.S. shot supplies by 100M each Emergency preparedness lessons for employers from COVID-19 Fierce Pharma Asia—Lilly-Junshi cocktail's emergency nod Featured Story | By Robert King The House Ways and Means Committee advanced legislation to expand eligibility for ACA tax credits as part of a $1.9 trillion COVID-19 relief package. read more |
| |
|---|
|
Top Stories By Fraiser Kansteiner Mallinckrodt will have to wait on a decision for its regenerative skin tissue therapy StrataGraft, after COVID-19 travel restrictions forced the FDA to delay yet another manufacturing plant inspection. It's a problem faced by many drugmakers in the pandemic era, from NASH-frontrunner Intercept to Bristol Myers Squibb. read more By Conor Hale BD has secured U.S. and European authorizations for a new COVID-19 test that screens for the coronavirus as well as influenza A and B—and the company said it’s shown to work against the emerging variants first identified in the U.K. and South Africa. read more By Robert King A new analysis gives a look at how COVID-19 caused Medicare fee-for-service claims to plummet in the first three months of the pandemic. read more By Fraiser Kansteiner,Eric Sagonowsky,Angus Liu,Conor Hale BD says its new combination COVID test should pick up virus variants, too. Mallinckrodt is the latest drugmaker hit by the FDA's pandemic-delayed inspection schedule. April should be "open season" for U.S. vaccinations, NIAID director Fauci said. North Carolina reported its first South African virus variant case. And Hungary started administering Russia's Sputnik V vaccine. read more By Paige Minemyer Employer benefits and human resources professionals should glean key lessons on emergency planning from the COVID-19 pandemic—and a new guide from the Northeast Business Group on Health aims to help set a baseline for those discussions. read more By Amirah Al Idrus Moderna is in talks with South Korea for a new $200 million vaccine production plant. Eli Lilly scored an emergency nod for its Junshi-partnered COVID-19 antibody cocktail. AstraZeneca joined forces with Hong Kong Science and Technology Parks to set up an incubator for startups working to improve the treatment and diagnosis of cancer. And more. read more |
|
